Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Recent-Onset Type 1 Diabetes Trial Evaluating Efficacy and Safety of Teplizumab (PROTECT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03875729
Recruitment Status : Recruiting
First Posted : March 15, 2019
Last Update Posted : October 11, 2019
Sponsor:
Information provided by (Responsible Party):
Provention Bio, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 2022
Estimated Study Completion Date : May 2022